In a meta-analysis, a thiazolidinedione and an alpha-glucosidase inhibitor were also found to be mortality-neutral in patients with diabetes mellitus type 2 and COVID-19 [53]. The gene discussed is GAA; the disease is type 2 diabetes mellitus.